Most drug development (preclinical and clinical) in diseases with 10 million or more cases per year. Kirk W. Kerr Thomas C. Henry Kathleen L. Miller 10.1371/journal.pntd.0006695.g004 https://plos.figshare.com/articles/figure/Most_drug_development_preclinical_and_clinical_in_diseases_with_10_million_or_more_cases_per_year_/6950387 <p>Most drug development (preclinical and clinical) in diseases with 10 million or more cases per year.</p> 2018-08-09 17:30:02 drug development priority review voucher program disease priority review voucher program